Seelos therapeutics announces appointment of margaret dalesandro to the board of directors

New york, sept. 2, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today the appointment of margaret dalesandro, ph.d.
SEEL Ratings Summary
SEEL Quant Ranking